SIM
CRBP icon

Sonora Investment Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Sonora Investment Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-40
Closed -$2K – 1698
2020
Q3 		$2K Hold
40
– – ﹤0.01% 1623
2020
Q2 		$10K Hold
40
– – ﹤0.01% 1100
2020
Q1 		$6K Hold
40
– – ﹤0.01% 1206
2019
Q4 		$7K Hold
40
– – ﹤0.01% 1308
2019
Q3 		$6K Sell
40
-7
-15% -$1.22K ﹤0.01% 1344
2019
Q2 		$10K Hold
47
– – ﹤0.01% 1169
2019
Q1 		$10K Hold
47
– – ﹤0.01% 1027
2018
Q4 		$8K Buy
+47
New +$9.38K ﹤0.01% 920

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sonora Investment Management's CRBP Position: Q4 2020 in Review

Sonora Investment Management sold out of Corbus Pharmaceuticals (CRBP) in Q4 2020, closing a stake of 40 shares — an estimated $2K sold.

Sonora Investment Management first reported a position in CRBP in Q4 2018 and held it in 8 quarters. The position peaked at $10K in Q2 2020. 107 funds tracked by Wall St. Rank hold CRBP as of Q4 2020.

  • Sonora Investment Management reported no remaining Corbus Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Sonora Investment Management sold 40 Corbus Pharmaceuticals shares in Q4 2020, an estimated $2K.
  • Sonora Investment Management first reported a position in Corbus Pharmaceuticals in Q4 2018 and held it in 8 quarters.
  • Sonora Investment Management's Corbus Pharmaceuticals position peaked at $10K in Q2 2020.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2020.

Based on Sonora Investment Management's 13F filing for Q4 2020, filed 13 Jan 2021.